DK435276A - Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved - Google Patents

Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved

Info

Publication number
DK435276A
DK435276A DK435276A DK435276A DK435276A DK 435276 A DK435276 A DK 435276A DK 435276 A DK435276 A DK 435276A DK 435276 A DK435276 A DK 435276A DK 435276 A DK435276 A DK 435276A
Authority
DK
Denmark
Prior art keywords
analoges
prostaglandin
procedure
production
intermediate products
Prior art date
Application number
DK435276A
Other languages
English (en)
Inventor
T K Schaaf
J S Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK435276A publication Critical patent/DK435276A/da
Priority to DK163879A priority Critical patent/DK163879A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK435276A 1975-09-29 1976-09-28 Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved DK435276A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK163879A DK163879A (da) 1975-09-29 1979-04-20 15-tetrahydropyranyloxyprostensyre-derivater til anvendelse som mellemprosukter ved fremstilling af prostaglandin-analoge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/617,481 US4065472A (en) 1975-09-29 1975-09-29 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins

Publications (1)

Publication Number Publication Date
DK435276A true DK435276A (da) 1977-03-30

Family

ID=24473823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK435276A DK435276A (da) 1975-09-29 1976-09-28 Fremgangsmade til fremstilling af prostaglandin-analoge og mellemprodukter til brug herved

Country Status (11)

Country Link
US (1) US4065472A (da)
JP (1) JPS5242872A (da)
BE (1) BE846650A (da)
CA (1) CA1085832A (da)
DE (1) DE2640692C3 (da)
DK (1) DK435276A (da)
FR (1) FR2325371A1 (da)
GB (1) GB1508925A (da)
IE (1) IE44067B1 (da)
LU (1) LU75904A1 (da)
NL (1) NL7610761A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
UA99840C2 (ru) * 2007-11-09 2012-10-10 Аллерган, Инк. Замещенные циклопентаны, которые имеют простагландиновую активность

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350971A (en) 1971-05-11 1974-04-24 Imp Chemi Als Ind Ltd Cyclopentane derivatives
US3922289A (en) * 1973-02-23 1975-11-25 Syntex Inc Trans-prostaglandin-like compounds and methods

Also Published As

Publication number Publication date
DE2640692B2 (da) 1979-01-18
IE44067B1 (en) 1981-08-12
LU75904A1 (da) 1977-05-11
FR2325371B1 (da) 1978-12-22
US4065472A (en) 1977-12-27
IE44067L (en) 1977-03-29
CA1085832A (en) 1980-09-16
JPS5437136B2 (da) 1979-11-13
GB1508925A (en) 1978-04-26
JPS5242872A (en) 1977-04-04
NL7610761A (nl) 1977-03-31
DE2640692C3 (de) 1979-09-13
FR2325371A1 (fr) 1977-04-22
BE846650A (fr) 1977-03-28
DE2640692A1 (de) 1977-03-31

Similar Documents

Publication Publication Date Title
DK455876A (da) Fremgangsmade til fremstilling af 5-pyridinyl-2(1h)-pyridinoner og mellemprodukter herved
DK449177A (da) Fremgangsmaade til fremstilling af staal
DK371276A (da) Fremgangsmade til fremstilling af kautsjuk og middel til udovelse af fremgangsmaden
DK76176A (da) Fremgangsmade til fremstilling af 6,7-benzomorphanderivater og mellemprodukter herfor
SE7600909L (sv) Forfarande for framstellning av livsmedel
DK554179A (da) Fremgangsmaade til fremstilling af ergolinderivater
IT1066078B (it) Procedimento per la produzione di surrogati di albume
SE7611091L (sv) Forfarande for uppslutning av xylanhaltiga naturprodukter
DK229476A (da) Prostanderivater og fremgangsmade til fremstilling deraf
SE426771B (sv) Forfarande for kontinuerlig framstellning av ost
IT1062629B (it) Procedimento per la produzione di cantaxantina
PL191647A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
BG27355A3 (bg) Метод за получаване на 11-дезокси-16-арилокси-w-тетранорпростагландини
IT1064107B (it) Procedimento per la produzione di nicotinammide
DK147676A (da) Fremgangsmade og anleg til kontinuerlig fremstilling af standardmelk
BG27543A3 (bg) Метод за получаване на n-арил-n-(1-l-4-пиперидинил)- арилацет-амиди
AR209622A1 (es) Procedimiento para la fabricacion de fosgeno
IT1058100B (it) Triisocianati biciclalifatici e procedimento per la loro froduzione ed applicazione
DK490076A (da) Fremgangsmade til fremstilling af 3-aminomethylen-6,7-dimethoxy-2-methyl-oxo1,2,3,4-tetrahydro-1-quinolin-carboxylsyre-estere og mellemprodukter herved
AR208001A1 (es) Procedimiento mejorado para la produccion de uroquinasa
DK575576A (da) Fremgangsmade til fremstilling af krystallinske former af natrium-cefamandol
IT1052928B (it) Procedimento per la produzione di floroglucina
RO69281A (ro) Procedeu pentru prepararea alchilamino-s-triazinelor
DK559975A (da) Fremgangsmade til fremstilling af 15-substituerede 11-desoxy-omega-pentanorprostaglandiner og mellemprodukter til anvendelse herved
IT1065601B (it) Procedimento per la produzione di diserbanti e prodotto ottenuto